Skip to content
Storytelling Co – Lifestyle
Author:
LB Pharmaceuticals Inc
LB Pharmaceuticals Initiates Pivotal Phase 3 Trial (NOVA-2) for LB-102 in Patients with Schizophrenia
March 25, 2026
←
Previous Page
1
2